相关实验视频

Updated: Sep 18, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

FAM111B过度表达和免疫细胞透:对卵巢癌免疫疗法的影响

Wanying Li¹, Fang Wei¹, Ting Zhou¹

¹Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

|June 26, 2025

概括

FAM111B基因与卵巢癌 (OC) 中免疫细胞透率的增加有关,可能会提高免疫疗法的有效性. 较高的FAM111B水平与较差的存活率相关,但可能会提高OC患者的治疗反应.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

卵巢癌 (OC) 的死亡率很高,并且在免疫学上"冷",限制了免疫治疗的成功.
在OC的瘤免疫微环境 (TIME) 中FAM111B的作用尚不清楚.
已知FAM111B可促进其他固体瘤的进展.

研究的目的:

在卵巢癌的时间内调查FAM111B的功能.
确定FAM111B表达和OC中的免疫细胞透之间的相关性.
评估FAM111B对患者存活率和免疫治疗相关标记物的影响.

主要方法:

多重体免疫光分析FAM111B和免疫标记物 (FOXP3,CD4,CD8,CD68,CD163,CD66b,CD11c) 的蛋白质表达.
使用癌症基因组图谱 (TCGA) 数据库进行生物信息学分析,以验证mRNA层面的FAM111B功能.
对FAM111B,免疫细胞透,生存数据和免疫检查点分子之间的相关性分析.

主要成果:

在OC中,FAM111B的表达与T细胞,巨细胞和树突细胞的透正相关.
增加的FAM111B,M2巨细胞和调节性T细胞与OC患者的整体存活率降低有关.
FAM111B水平与免疫检查点分子相关,包括编程死亡配体1 (PD-L1) 和T细胞/树突细胞透.

结论:

过度表达FAM111B与OC瘤免疫微环境中的免疫细胞透率增加有关.
在高FAM111B的OC患者中增强免疫细胞透可能会改善免疫治疗的疗效.
在卵巢癌中,FAM111B是预测免疫治疗反应的潜在生物标志物.

关键词:

这就是FAM111B.免疫细胞的透.免疫疗法免疫疗法卵巢癌是发生在卵巢的癌症.瘤免疫的微环境

更多相关视频

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.